Sultana Reshmi, Sailaja Suryadevara
Department of General Surgery, Senior Resident, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana 508126, India.
Department of Surgical Oncology, Consultant Surgical Oncologist, Alluri Sitaramaraju Academy of Medical Sciences, Eluru, Andhra Pradesh 534005, India.
Oncoscience. 2025 Sep 4;12:91-95. doi: 10.18632/oncoscience.624. eCollection 2025.
Adult fibrosarcoma is a rare and aggressive soft tissue malignancy originating from spindle-shaped fibroblasts, primarily affecting deep soft tissues in the extremities, trunk, head, and neck. Surgical resection with R0 margins remains the gold standard, with adjuvant radiation therapy recommended for large or high-grade tumors to reduce recurrence risk. Chemotherapy and immunotherapy play complementary roles in disease management, with emerging strategies targeting matrix metalloproteinases and tumor microenvironment interactions to enhance chemosensitivity and overcome drug resistance. Despite advances in treatment, prognosis remains poor due to the tumor's aggressive nature. However, early detection with complete surgical excision and multimodal therapies offer the best prospects for improved patient survival.
成人纤维肉瘤是一种罕见且侵袭性强的软组织恶性肿瘤,起源于梭形成纤维细胞,主要影响四肢、躯干、头部和颈部的深部软组织。切缘阴性的手术切除仍是金标准,对于大型或高级别肿瘤,建议辅助放疗以降低复发风险。化疗和免疫疗法在疾病管理中发挥着互补作用,新出现的策略是针对基质金属蛋白酶和肿瘤微环境相互作用,以增强化疗敏感性并克服耐药性。尽管治疗取得了进展,但由于肿瘤的侵袭性,预后仍然很差。然而,早期检测并进行完整的手术切除和多模式治疗为提高患者生存率提供了最佳前景。